CHRNA5 links chandelier cells to protection against amyloid pathology in human aging and Alzheimer's Disease

Author:

Rybnicek Jonas,Chen Yuxiao,Millic Milos,McLaurin JoAnne,De Jager Philip1ORCID,Schneider Julie2,Wang Yanling,Bennett David2,Tripathy Shreejoy3,Felsky Daniel,Lambe Evelyn4ORCID

Affiliation:

1. Columbia University Medical Center

2. Rush University Medical Center

3. University of Toronto and Centre for Addiction and Mental Health

4. University of Toronto

Abstract

Abstract Changes in high-affinity nicotinic acetylcholine receptors are intricately connected to neuropathology in Alzheimer’s Disease (AD). Protective and cognitive-enhancing roles for the nicotinic α5 subunit have been identified, but this gene has not been closely examined in the context of human aging and dementia. Therefore, we investigate the nicotinic α5 gene CHRNA5 and the impact of relevant single nucleotide polymorphisms (SNPs) in prefrontal cortex from 922 individuals with matched genotypic and post-mortem RNA sequencing in the Religious Orders Study and Memory and Aging Project (ROS/MAP). We find that a genotype robustly linked to expression of CHRNA5 (rs1979905A2) predicts significantly reduced β-amyloid load in prefrontal cortex. Yet, co-expression analysis shows a clear dissociation between expression of CHRNA5 and other cholinergic genes, suggesting a distinct cellular expression profile for the human nicotinic α5 subunit. Consistent with this prediction, single nucleus RNA sequencing from 22 individuals reveals disproportionately-elevated CHRNA5 expression in chandelier cells. These interneurons are enriched in amyloid-binding proteins and also play a vital role in excitatory/inhibitory (E/I) balance. Cell-type proportion analysis demonstrates that chandelier cells have increased amyloid vulnerability in individuals homozygous for the missense CHRNA5 SNP (rs16969968A2) that impairs function/trafficking of nicotinic α5-containing receptors. These findings suggest that CHRNA5 and its nicotinic α5 subunit exert a neuroprotective role in aging and Alzheimer's disease potentially centered on chandelier interneurons.

Publisher

Research Square Platform LLC

Reference75 articles.

1. Hampel H, Mesulam M-M, Cuello AC, Farlow MR, Giacobini E, Grossberg GT, et al. The cholinergic system in the pathophysiology and treatment of Alzheimer’s disease. Brain. 2018 Jul 1;141(7):1917–33. Available from: https://pubmed.ncbi.nlm.nih.gov/29850777

2. Busche MA, Hyman BT. Synergy between amyloid-β and tau in Alzheimer’s disease. Nat Neurosci. 2020;23(10):1183–93. Available from: https://doi.org/10.1038/s41593-020-0687-6

3. Lauterborn JC, Scaduto P, Cox CD, Schulmann A, Lynch G, Gall CM, et al. Increased excitatory to inhibitory synaptic ratio in parietal cortex samples from individuals with Alzheimer’s disease. Nat Commun. 2021;12(1):2603. Available from: https://doi.org/10.1038/s41467-021-22742-8

4. Vico Varela E, Etter G, Williams S. Excitatory-inhibitory imbalance in Alzheimer’s disease and therapeutic significance. Neurobiol Dis. 2019;127:605–15. Available from: https://www.sciencedirect.com/science/article/pii/S0969996118307599

5. Pafundo DE, Miyamae T, Lewis DA, Gonzalez-Burgos G. Cholinergic modulation of neuronal excitability and recurrent excitation-inhibition in prefrontal cortex circuits: implications for gamma oscillations. J Physiol. 2013/07/01. 2013 Oct 1;591(19):4725–48. Available from: https://pubmed.ncbi.nlm.nih.gov/23818693

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3